SYNDROS (dronabinol) is the First and Only FDA-Approved CII Tetrahydrocannabinol (THC), a liquid cannabinoid used in adults to treat:

  • Nausea and vomiting caused by anti-cancer medicine (chemotherapy) in people whose nausea and vomiting have not improved with usual anti-nausea medicines.
  • Loss of appetite (anorexia) in people with AIDS (Acquired Immune Deficiency Syndrome) who have lost weight.

What Is SYNDROS →

Treatment for
Breakthrough CINV

SYNDROS (dronabinol) a CII Tetrahydrocannabinol (THC), a liquid cannabinoid used in adults to treat nausea and vomiting caused by anti-cancer medicine (chemotherapy) in people whose nausea and vomiting have not improved with usual anti-nausea medicines.

Learn More About CINV & SYNDROS →

Appetite Stimulation for
AIDS-related Weight Loss

SYNDROS (dronabinol) a CII Tetrahydrocannabinol (THC), a liquid cannabinoid used in adults to treat the loss of appetite (anorexia) in people with AIDS (Acquired Immune Deficiency Syndrome) who have lost weight.

Learn more about SYNDROS for appetite stimulation →

Models, not actual patients.
  1. Free Trial Bottle Voucher Program for New Patients
    • One (1) 30 mL Bottle per New Patient
  2. Pay as little as $0 co-pay for Each Prescription
    • For commercially-insured patients
  3. Cash Pay Discount up to $400 Off Per Bottle

Is SYNDROS an option for you?

Adult patients with Cancer and/or AIDS may benefit from SYNDROS (dronabinol) which is the First and Only FDA-Approved CII Tetrahydrocannabinol (THC), a liquid cannabinoid used to treat:
  • Nausea and vomiting caused by anti-cancer medicine (chemotherapy) in people whose nausea and vomiting have not improved with usual anti-nausea medicines.
  • Loss of appetite (anorexia) in people with AIDS (Acquired Immune Deficiency Syndrome) who have lost weight.
SYNDROS® is now distributed by Benuvia Therapeutics Inc.

Chemotherapy-Induced Nausea and Vomiting (CINV)

Many adult patients on antiemetics still experience nausea and vomiting while receiving chemotherapy, 30-50% of adult patients receiving moderately or highly emetogenic chemotherapy continue to experience breakthrough CINV, despite the progressive introduction of antiemetic (anti-nausea) agents.

Anorexia Associated with Weight Loss in Adult Patients with AIDS

Many adult patients in the United States with AIDS may experience anorexia associated weight loss, despite the use of highly active antiretroviral therapy, it is estimated that the prevalence of HIV wasting syndrome is between 14% and 38%.

Do Not Take SYNDROS If You:

Had an allergic reaction to dronabinol. Signs and symptoms of an allergic reaction to dronabinol include: swelling of the lips, hives, a rash over your whole body, mouth sores, skin burning, flushing and throat tightness.

Had an allergic reaction to alcohol.

Are using a medicine that contains disulfiram (Antabuse) or metronidazole (Pylera, Flagyl, Flagyl ER, Nuvessa, Vandazole) or have taken or received a medicine that contains disulfiram or metronidazole in the last 14 days.

Benuvia Therapeutics Patient Services Center

Our adult patient services program, SYNDROS CARES®, is designed with adult patients in mind. The SYNDROS CARES® program offers support for commercially insured and cash paying patients including a Free Trial Voucher and Discount Card.